Confirmatory Study Nepafenac 0.3%

NCT01109173 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alcon Research